Shocking news re new CMA investigation into medicines pricing. Now wholesalers are provisionally found guilty of price fixing with pharma manufacturers. Meanwhile liothyronine price issues remain unresolved too and thyroid patients continue to be harmed.
So grateful @MichaelRosenYes is interested in thyroid disease. Most people don't understand how much it affects people's lives, especially as many are poorly treated. Also many are refused the drugs they need #andmeT3
Such a professional survey. Thank you ITT so much for this. NICE need to understand the depth of feeling from thyroid patients about the lack of understanding of drs. Patients deserve better.
As a reminder, the survey results presentation can be located here: https://t.co/rYgo2Ykyfo
The executive level summary of the survey findings can be located here: https://t.co/eDA1lXzN53
If you would like quick access to all 3 documents, click here: https://t.co/PCMaDYmDmZ
If you would like to read our formal response to the NICE Draft Guideline on thyroid disease, you can do so by clicking this link:
https://t.co/wLKb6gvE10
Thank you to everyone who helped contribute to our response including the 2022 people who filled in our survey! ❤️🦋
We are pleased to see that @Britishgenerics and @OxeraConsulting are happy with their report on generics. Unfortunately, thousands of thyroid patients are not happy with one generic - https://t.co/fM8VcBW8qv
Gender bias in healthcare is killing women and has to stop. We need a campaign to educate women so they recognize symptoms, seek medical advice and refuse to be dismissed by HCPs because our symptoms aren't classic text book symptoms @TheBHF@paulasherriff
Have you booked your place on our "Confidence in Menopause: a practical approach to primary care" educational event in September? This event is for healthcare professionals to gain a better understanding of #menopause. Click here to register your place: https://t.co/taYpiytH6O
Trivialising sub headline. But good content. These patients suffer awful symptoms but are denied the drug the need. Because NHS pays a huge price for a drug that's cheap elsewhere. WHY? @MattHancock we are STILL asking for your help #andmeT3
If you are on long term levothyroxine therapy and your doctor will only prescribe for 1 or 2 months supply at a time, you might find this article worth sharing with them. From @britishthyroid newsletter 70 https://t.co/6qAURMP2k8
THE RESULTS ARE IN!
We recently asked you to complete a survey to help ITT formulate a response to the NICE Draft Guideline, Thyroid disease: assessment and management.
To access the FULL SURVEY PRESENTATION (or Executive Summary if you prefer) click 👇🏼
https://t.co/NzXeUwe5YD
THE RESULTS ARE IN!
We recently asked you to complete a survey to help ITT formulate a response to the NICE Draft Guideline, Thyroid disease: assessment and management.
To access the FULL SURVEY PRESENTATION (or Executive Summary if you prefer) click 👇🏼
https://t.co/NzXeUwe5YD